Blog

EPO Revokes Broad’s CRISPR Patent – The Scientist


The Scientist

EPO Revokes Broad's CRISPR Patent
The Scientist
In addition to the highly publicized patent dispute between the Broad and the University of California over the rights to CRISPR gene editing in the U.S., the Broad has been fighting to maintain a number of patents over the technology in Europe. The
UK: Broad Institute CRISPR Patent Revoked By EPOMondaq News Alerts



all 4 news articles »

2018-01-17 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.